Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Busulfan, Cyclophosphamide, Antithymocyte Globulin2件: Busulfan,
Cyclophosphamide		3件: D00248 ,
D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 19, 20
2Busulfan, Cyclophosphamide, ATG2件: Busulfan,
Cyclophosphamide		3件: D00248 ,
D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 19
3Busulfan, Cyclophosphamide, ATG, GCSF2件: Busulfan,
Cyclophosphamide		3件: D00248 ,
D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 65, 284
4Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)4件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Cyclophosphamide,
Fludarabine		5件: D00248 ,
D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 326
5Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.4件: Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		6件: D00184 ,
D00248 ,
D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 285
6Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284
7Cyclophosphamid1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 66
8Cyclophosphamide1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--45件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331
9Cyclophosphamide (CY)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
10Cyclophosphamide (CY) (Plan 1)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 60, 285
11Cyclophosphamide (CY) (Plan 2)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 60, 285
12Cyclophosphamide (Cytoxan)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 65
13Cyclophosphamide (drug)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 13
14Cyclophosphamide + pred1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 283
15Cyclophosphamide 100mg1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
16Cyclophosphamide 150mg1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
17Cyclophosphamide 301件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--3件: 65, 285, 326
18Cyclophosphamide 401件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--3件: 65, 285, 326
19Cyclophosphamide 50mg1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
20Cyclophosphamide 50Mg Oral Tablet1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 162
21Cyclophosphamide and ATG1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 13
22Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 13
23Cyclophosphamide and steroids1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 222
24Cyclophosphamide Dose Level 11件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 65, 284
25Cyclophosphamide Dose Level 21件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 65, 284
26Cyclophosphamide Dose Level 31件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 65, 284
27Cyclophosphamide Dose Level 41件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--2件: 65, 284
28Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids3件: Azathioprine,
Cyclophosphamide,
Methotrexate		6件: D00142 ,
D00238 ,
D00287 (Name: Cyclophosphamide),
D02115 ,
D03033 ,
D07760 (Name: Cyclophosphamide)		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44
29Cyclophosphamide Injection 1g1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--3件: 50, 51, 52
30CYCLOPHOSPHAMIDE MONOHYDRATE1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--4件: 13, 60, 96, 256
31Cyclophosphamide post transplant1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 65
32Cyclophosphamide(CTX)1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 224
33Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		11件: D00238 ,
D00287 (Name: Cyclophosphamide),
D00407 ,
D00473 ,
D00751 ,
D00979 ,
D03033 ,
D05000 ,
D05001 ,
D05002 ,
D07760 (Name: Cyclophosphamide)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45
34Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		12件: D00287 (Name: Cyclophosphamide),
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760 (Name: Cyclophosphamide)		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
35Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		12件: D00287 (Name: Cyclophosphamide),
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760 (Name: Cyclophosphamide)		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
36Cyclophosphamide, Bortezomib, dexamethasone3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		12件: D00287 (Name: Cyclophosphamide),
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760 (Name: Cyclophosphamide)		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
37Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		13件: D00287 (Name: Cyclophosphamide),
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760 (Name: Cyclophosphamide),
D10777 		3件: CD38,
NR3C1,
PSMB5 💬		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28
38Cyclophosphamide, Fludarabine2件: Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 285
39Cyclophosphamide, fludarabine , thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
40Cyclophosphamide, Fludarabine, Rabbit ATG4件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine,
Rabbit		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
41Cyclophosphamide, Fludarabine, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
42Cyclophosphamide,Campath IH and TBI1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
43Cyclophosphamide,cyclosporine A2件: Cyclophosphamide,
Cyclosporine		3件: D00184 ,
D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60
44Cyclophosphamide-prednisone-azathioprine3件: Azathioprine,
Cyclophosphamide,
Prednisone		5件: D00238 ,
D00287 (Name: Cyclophosphamide),
D00473 ,
D03033 ,
D07760 (Name: Cyclophosphamide)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
45Cyclophosphamide/azathioprine2件: Azathioprine,
Cyclophosphamide		4件: D00238 ,
D00287 (Name: Cyclophosphamide),
D03033 ,
D07760 (Name: Cyclophosphamide)		--1件: 44
46Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		3件: D00287 (Name: Cyclophosphamide),
D04318 ,
D07760 (Name: Cyclophosphamide)		20件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13
47Cyclophosphamidum1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 44
48Cyclophosphamidum 500 mg1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 44
49Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate		6件: D00142 ,
D00287 (Name: Cyclophosphamide),
D02115 ,
D02997 ,
D03899 ,
D07760 (Name: Cyclophosphamide)		4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65
50Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: D00287 (Name: Cyclophosphamide),
D01907 ,
D07760 (Name: Cyclophosphamide),
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
51Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 60
52High-dose Cyclophosphamide1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 96
53IV Cyclophosphamide1件: Cyclophosphamide2件: D00287 (Name: Cyclophosphamide),
D07760 (Name: Cyclophosphamide)		--1件: 51
54Lenalidomide, Dexamethasone and Cyclophosphamide3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		12件: D00287 (Name: Cyclophosphamide),
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687 ,
D07760 (Name: Cyclophosphamide)		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
55Prednisone and cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 (Name: Cyclophosphamide),
D00473 ,
D07760 (Name: Cyclophosphamide)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
56Prednisone plus cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 (Name: Cyclophosphamide),
D00473 ,
D07760 (Name: Cyclophosphamide)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
57Prednisone, cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 (Name: Cyclophosphamide),
D00473 ,
D07760 (Name: Cyclophosphamide)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 40
58Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		7件: D00407 ,
D00473 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45
59Rituximab and Cyclophosphamide IV2件: Cyclophosphamide,
Rituximab		3件: D00287 (Name: Cyclophosphamide),
D02994 ,
D07760 (Name: Cyclophosphamide)		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 35
60Thalidomide, cyclophosphamide and prednisone3件: Cyclophosphamide,
Prednisone,
Thalidomide		4件: D00287 (Name: Cyclophosphamide),
D00473 ,
D00754 ,
D07760 (Name: Cyclophosphamide)		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331